A detailed history of Ghisallo Capital Management LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ghisallo Capital Management LLC holds 33,750 shares of BBIO stock, worth $937,237. This represents 0.08% of its overall portfolio holdings.

Number of Shares
33,750
Previous 33,750 -0.0%
Holding current value
$937,237
Previous $854,000 0.59%
% of portfolio
0.08%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$23.0 - $31.04 $776,250 - $1.05 Million
-33,750 Reduced 50.0%
33,750 $854,000
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $1.85 Million - $2.73 Million
67,500 New
67,500 $2.09 Million
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $1.47 Million - $3.8 Million
205,000 New
205,000 $3.4 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.12B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Ghisallo Capital Management LLC Portfolio

Follow Ghisallo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghisallo Capital Management LLC with notifications on news.